Company profile · Wroclaw, Poland

Pure Biologics S.A.

Antibody and Aptamer Discovery, Immuno-Oncology, and Extracorporeal Apheresis · ISO 17025 plus GMP-capable medium-scale production

Wroclaw antibody and aptamer biotech with named co-founder CEO, ISO 17025 accreditation, GLP and GMP-capable medium-scale production, and a Business Garden lab facility.

Lead
Filip Jelen (verified ↗)
Address
ul. Legnicka, Business Garden Wroclaw, Wroclaw, Poland (source ↗)
Compliance
PN-EN ISO 17025 · GLP and GMP-capable production
Last reviewed
24 Apr 2026 (1mo ago)
Scale
ISO 17025 plus GMP-capable medium-scale production
Capabilities
Antibody Discovery Platforms · PureApta Aptamer Platform · Extracorporeal Apheresis Therapies
Founded
2010
Headcount
51-200
LinkedIn
Company page (open ↗)
Site and address
Clinical profileSTATUS: VERIFIED APRIL 2026

Filip Jelen

Chief Executive Officer and Co-Founder

Check official leadership source
Full addressul. Legnicka, Business Garden Wroclaw, Wroclaw, Poland
Site coordinatesVerification evidence is still being completed.
Review cycle24 April 2026
Physical site source

Business Garden Wroclaw lease announcement for Pure Biologics.

Open source
Operating profile

ISO 17025 plus GMP-capable medium-scale production

Wroclaw, Poland. Antibody and Aptamer Discovery, Immuno-Oncology, and Extracorporeal Apheresis. Review completed on 24 Apr 2026.

2026 technical specializationAntibody and Aptamer Discovery, Immuno-Oncology, and Extracorporeal Apheresis
Core capabilities
Antibody Discovery PlatformsPureApta Aptamer PlatformExtracorporeal Apheresis Therapies
Governance

Polish Office for Registration of Medicinal Products and EMA for future oversight

PN-EN ISO 17025, GLP and GMP-capable production, Public team-page CEO disclosure

Editorial note

Antibody and Aptamer Discovery, Immuno-Oncology, and Extracorporeal Apheresis

Wroclaw antibody and aptamer biotech with named co-founder CEO, ISO 17025 accreditation, GLP and GMP-capable medium-scale production, and a Business Garden lab facility.

Editorial note

Pure Biologics is a Wroclaw antibody and aptamer biotech with a named co-founder CEO, ISO 17025 accreditation, GLP and GMP-capable medium-scale production, and a Business Garden lab facility.

FULL TRUST REVIEW COMPLETE
Shown only when all seven trust checks are fully mapped in the directory.
Current review cycleApril 2026Last reviewed: 24 April 2026
Capabilities

Core capabilities

Primary declared technical activities and areas of operating focus.

Antibody Discovery Platforms
PureApta Aptamer Platform
Extracorporeal Apheresis Therapies
Verification source dossier

Verification source dossier

Official source set used to support leadership, physical-site, certification, and watch-note evidence.

Leadership evidencePure Biologics team page naming Filip Jelen as CEO and Co-founder.Source origin: purebiologics.comOpen source
Supporting evidenceNorthData KRS registry entry for Pure Biologics S.A.Source origin: northdata.comOpen source
Physical-site evidenceBusiness Garden Wroclaw lease announcement for Pure Biologics.Source origin: businessgarden.euOpen source
Infrastructure

Declared infrastructure

Antibody discovery platforms
Aptamer discovery workflow
Medium-scale biologics production
Regulatory posture

Quality system coverage

GMP / GLP / ISO-13485 / FDA-Inspected are global quality-system standards. "Verified active" means the directory confirmed the certification is current; "Review in progress" means the cert status is currently being re-verified.

GMP
VERIFIED ACTIVE 2026
GLP
VERIFIED ACTIVE 2026
ISO-13485
REVIEW IN PROGRESS 2026
FDA-Inspected
REVIEW IN PROGRESS 2026
Verification history

Verification history

24 Apr 2026: Executive identity confirmed via official management disclosure.
24 Apr 2026: Full trust review completed.
FAQ

Frequently asked questions

Where is Pure Biologics S.A. located?
Pure Biologics S.A. operates from ul. Legnicka, Business Garden Wroclaw, Wroclaw, Poland, Wroclaw, Poland.
Who runs Pure Biologics S.A.?
Pure Biologics S.A. is led by Filip Jelen, Chief Executive Officer and Co-Founder. Verified 24 Apr 2026.
What certifications does Pure Biologics S.A. hold?
Pure Biologics S.A. is documented under PN-EN ISO 17025, GLP and GMP-capable production.
What does Pure Biologics S.A. do?
Wroclaw antibody and aptamer biotech with named co-founder CEO, ISO 17025 accreditation, GLP and GMP-capable medium-scale production, and a Business Garden lab facility. Core capabilities: Antibody Discovery Platforms, PureApta Aptamer Platform, Extracorporeal Apheresis Therapies.
Editorial context

Related technical briefs

Briefs that name Wroclaw as a covered market or city.